Table 3

Hematopoietic character of ossicle bone marrow

Lineage (n = 5)Control ossiclePTH ossicleControl femurPTH femur
Mac-1+Gr-1+, myeloid cells 26.42 ± 5.05 33.63 ± 1.93 50.85 ± 2.42 37.93 ± 4.58 
Ter119+, erythroid progenitors 79.13 ± 7.07* 68.68 ± 7.29 39.47 ± 2.27 54.77 ± 4.94 
B220+ cells 8.46 ± 1.39 10.95 ± 1.07 20.53 ± 2.08 17.16 ± 1.84 
B220+sIgMCD43 (pre-B) 2.09 ± 0.52 3.29 ± 0.80 9.81 ± 0.23 7.39 ± 0.65 
B220+sIgMCD43low (pro-B) 1.88 ± 0.28 1.88 ± 0.31 4.32 ± 1.09 3.78 ± 0.53 
B220+sIgMCD43+ (pre-pro-B) 0.40 ± 0.05 0.37 ± 0.18 1.68 ± 0.52 1.43 ± 0.36 
B220+ sIgM+ B cells 3.82 ± 1.32 5.13 ± 0.79 4.00 ± 0.58 3.95 ± 0.48 
B220 sIgM B cells 7.93 ± 0.84 6.83 ± 1.34 17.21 ± 1.50 13.85 ± 1.59 
T cells 5.71 ± 1.80 6.8 ± 0.49 2.80 ± 0.64 3.14 ± 1.16 
Helper T cells 4.94 ± 1.93 5.94 ± 0.73 2.56 ± 0.60 2.84 ± 1.14 
Cytotoxic T cells 0.11 ± 0.11 0.11 ± 0.05 0.03 ± 0.01 0.05 ± 0.00 
Lineage (n = 5)Control ossiclePTH ossicleControl femurPTH femur
Mac-1+Gr-1+, myeloid cells 26.42 ± 5.05 33.63 ± 1.93 50.85 ± 2.42 37.93 ± 4.58 
Ter119+, erythroid progenitors 79.13 ± 7.07* 68.68 ± 7.29 39.47 ± 2.27 54.77 ± 4.94 
B220+ cells 8.46 ± 1.39 10.95 ± 1.07 20.53 ± 2.08 17.16 ± 1.84 
B220+sIgMCD43 (pre-B) 2.09 ± 0.52 3.29 ± 0.80 9.81 ± 0.23 7.39 ± 0.65 
B220+sIgMCD43low (pro-B) 1.88 ± 0.28 1.88 ± 0.31 4.32 ± 1.09 3.78 ± 0.53 
B220+sIgMCD43+ (pre-pro-B) 0.40 ± 0.05 0.37 ± 0.18 1.68 ± 0.52 1.43 ± 0.36 
B220+ sIgM+ B cells 3.82 ± 1.32 5.13 ± 0.79 4.00 ± 0.58 3.95 ± 0.48 
B220 sIgM B cells 7.93 ± 0.84 6.83 ± 1.34 17.21 ± 1.50 13.85 ± 1.59 
T cells 5.71 ± 1.80 6.8 ± 0.49 2.80 ± 0.64 3.14 ± 1.16 
Helper T cells 4.94 ± 1.93 5.94 ± 0.73 2.56 ± 0.60 2.84 ± 1.14 
Cytotoxic T cells 0.11 ± 0.11 0.11 ± 0.05 0.03 ± 0.01 0.05 ± 0.00 

Data are mean ± SD.

*

Femur versus ossicle (P < .01).

PTH versus control ossicle or femur (P < .01).

Close Modal

or Create an Account

Close Modal
Close Modal